Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma
Status:
Terminated
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
This research study is evaluating a study drug to treat pancreatic exocrine insufficiency
(PEI) during the first year after the diagnosis of pancreatic cancer while the participant is
recovering from surgery and receiving adjuvant treatment.
The study drug involved in this study is:
-Zenpep